-
Founded in:
1993-12-31 -
Country:
China -
Address:
No. 2158 Huangpujiang Middle Road, Kunshan Development Zone, Jiangsu Province -
Tax NO.:
91320583608278334C -
Registered Funds:
$25,416,780 -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Benzbromarone |
This product is a benzofuran derivative and a uricosuric drug. Its mechanism of action is mainly to inhibit the reabsorption of uric acid by the renal tubules, thereby reducing the concentration of uric acid in the blood.
More
This product is a benzofuran derivative and a uricosuric drug. Its mechanism of action is mainly to inhibit the reabsorption of uric acid by the renal tubules, thereby reducing the concentration of uric acid in the blood. |
3562-84-3 | 8 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ramiprilat |
Ramipril is a prodrug that is absorbed from the gastrointestinal tract and hydrolyzed in the liver into the active angiotensin converting enzyme (ACE) inhibitor ramiprilat to exert its effect. Taking ramipril can lead to an increase in plasma renin activity and a decrease in plasma concentrations of angiotensin II and aldosterone. Because of the reduction of angiotensin II, ACE inhibitors can lead to peripheral vasodilation and a decrease in vascular resistance, thereby producing beneficial hemodynamic effects.
More
Ramipril is a prodrug that is absorbed from the gastrointestinal tract and hydrolyzed in the liver into the active angiotensin converting enzyme (ACE) inhibitor ramiprilat to exert its effect. Taking ramipril can lead to an increase in plasma renin activity and a decrease in plasma concentrations of angiotensin II and aldosterone. Because of the reduction of angiotensin II, ACE inhibitors can lead to peripheral vasodilation and a decrease in vascular resistance, thereby producing beneficial hemodynamic effects. |
87269-97-4 | 15 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ramiprilat |
Ramipril is a prodrug that is absorbed from the gastrointestinal tract and hydrolyzed in the liver into the active angiotensin converting enzyme (ACE) inhibitor ramiprilat to exert its effect. Taking ramipril can lead to an increase in plasma renin activity and a decrease in plasma concentrations of angiotensin II and aldosterone. Because of the reduction of angiotensin II, ACE inhibitors can lead to peripheral vasodilation and a decrease in vascular resistance, thereby producing beneficial hemodynamic effects.
More
Ramipril is a prodrug that is absorbed from the gastrointestinal tract and hydrolyzed in the liver into the active angiotensin converting enzyme (ACE) inhibitor ramiprilat to exert its effect. Taking ramipril can lead to an increase in plasma renin activity and a decrease in plasma concentrations of angiotensin II and aldosterone. Because of the reduction of angiotensin II, ACE inhibitors can lead to peripheral vasodilation and a decrease in vascular resistance, thereby producing beneficial hemodynamic effects. |
87269-97-4 | 15 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ramiprilat |
Ramipril is a prodrug that is absorbed through the gastrointestinal tract and hydrolyzed in the liver into an active angiotensin converting enzyme (ACE) inhibitor, ramiprilat, to exert its effect. Taking ramipril can lead to an increase in plasma renin activity and a decrease in plasma concentrations of angiotensin II and aldosterone. Because of the reduction of angiotensin II, ACE inhibitors can lead to peripheral vasodilation and a decrease in vascular resistance, thereby producing a beneficial hemodynamic effect.
More
Ramipril is a prodrug that is absorbed through the gastrointestinal tract and hydrolyzed in the liver into an active angiotensin converting enzyme (ACE) inhibitor, ramiprilat, to exert its effect. Taking ramipril can lead to an increase in plasma renin activity and a decrease in plasma concentrations of angiotensin II and aldosterone. Because of the reduction of angiotensin II, ACE inhibitors can lead to peripheral vasodilation and a decrease in vascular resistance, thereby producing a beneficial hemodynamic effect. |
87269-97-4 | 15 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ramiprilat |
Ramipril is a prodrug that is absorbed from the gastrointestinal tract and hydrolyzed in the liver into the active angiotensin converting enzyme (ACE) inhibitor ramiprilat to exert its effect. Taking ramipril can lead to an increase in plasma renin activity and a decrease in plasma concentrations of angiotensin II and aldosterone. Because of the reduction of angiotensin II, ACE inhibitors can lead to peripheral vasodilation and a decrease in vascular resistance, thereby producing a beneficial hemodynamic effect.
More
Ramipril is a prodrug that is absorbed from the gastrointestinal tract and hydrolyzed in the liver into the active angiotensin converting enzyme (ACE) inhibitor ramiprilat to exert its effect. Taking ramipril can lead to an increase in plasma renin activity and a decrease in plasma concentrations of angiotensin II and aldosterone. Because of the reduction of angiotensin II, ACE inhibitors can lead to peripheral vasodilation and a decrease in vascular resistance, thereby producing a beneficial hemodynamic effect. |
87269-97-4 | 15 |